Companies in the oncology sector developing innovative solutions and technologies.
Explore 311 recently funded oncology companies with verified founder contact information and fundraising data.
Nanoligent aim is the research and development to clinical phases of innovative cancer treatments based on protein nanoparticles.
Kivu Bioscience is a biotechnology company that focuses on developing next-generation antibody-drug conjugates to target cancer.
Repare Therapeutics is a developer of oncology drugs designed to target specific vulnerabilities of tumor cells.
X4 Pharmaceuticals is a clinical-stage oncology company developing oral small molecule CXCR4 antagonists for the treatment.
Onc.AI is a software that specializes in clinical oncology, genomics, proteomics, and radiomics.
OncoC4 is a biopharmaceutical company that engages in the discovery and development of novel biologicals for cancer treatment.
Adaptiiv specializes in medical device and software development that helps practitioners in cancer treatment operations.
Actym Therapeutics is a biotech company that focuses on the discovery and development of novel immuno-oncology therapies to treat cancer.
AUM Biosciences is committed to addressing the unmet medical needs by developing innovative and affordable oncology therapeutics for Asia.
BioTwin Preventative Health and Decision Support Tools based on Human Virtual Twin derived from biometrics & biomarkers
LUMICKS provides single-molecule analysis technologies for cancer research and immunotherapy.
The oncology sector is an active area of startup innovation and venture capital investment. Companies in this space are developing new technologies, platforms, and services that address evolving market needs and create new business opportunities.
Oncology companies raise capital across various funding stages, from early seed rounds to late-stage growth financing. Investor interest in this sector is driven by the size of the addressable market, the pace of technology adoption, and the potential for scalable business models.
The oncology sector is expected to continue evolving as technology advances, market dynamics shift, and new opportunities emerge. Companies that demonstrate strong product-market fit, efficient growth, and clear competitive advantages are well-positioned to attract continued investment.
Here is how funding is distributed among the 311 oncology companies tracked in the VCBacked database.
Companies in the oncology sector often overlap with or complement businesses in adjacent industries. Exploring related verticals can help you discover additional companies, identify partnership opportunities, and understand the broader competitive landscape.
Perfect for: B2B sales teams targeting oncology companies, investors exploring sector opportunities, and service providers looking for funded companies ready to scale.
Get Started - Access Contact InformationJoin thousands of sales teams, investors, and service providers using VCBacked